Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease - KIVIRID

Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease

Authors: Jake S O’Donnell, Noushin Jaberolansar, Keith J Chappell

Published: 2024-01-18

DOI: 10.1016/s2666-5247(23)00359-2

Source: Full article

Abstract

No abstract found.